*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack GlobeNewswire
Market data is delayed by at least 15 minutes.
    Latest Story
    E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack
     GlobeNewswire
    Full Story →

    Headline News
    E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing
    1:19p ET July 17 '26 GlobeNewswire
    Glucotrack, Inc. and Lōkahi Therapeutics(TM) Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives
    8:04a ET July 17 '26 GlobeNewswire
    UPDATE - Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform
    4:57p ET July 16 '26 GlobeNewswire
    More News →
    Day  21.05%Week  14.43%Month  53.49%More Charting →
    September 11 '26. Markets Closed.
    Last $2.55
    Day change   21.05%$0.68
    Open $3.06
    Gap at open $0.17
    Previous close $3.23
    Trading volume 744,247
    10 Day avg vol. 145,195
    Shares out. 798.0K
    Market cap. $2.0Mil
    Trading activity Above Avg.
    Previous data from yesterday, September 10 '26.

    Historical Price Performance
    3 month   56.00% 
    6 month   84.96% 
    1 year   98.39% 
    2 year   100.00% 

    Earnings
    Previous 12m -$12.02
    Next 12m Estimate NM
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by